External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients [Poster]
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Radiotherapy and Oncology, 115, S. S333-S334
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2015
- Event
-
Veröffentlichung
- (who)
-
Elsevier BV
- (when)
-
2015
- Creator
-
Krenn-Pilko, S.
Langsenlehner, U.
Thurner, E.M.
Stojakovic, T.
Pichler, Martin
Gerger, A.
Kapp, K.S.
Langsenlehner, T.
- DOI
-
10.1016/s0167-8140(15)40674-7
- URN
-
urn:nbn:de:bvb:384-opus4-1036075
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krenn-Pilko, S.
- Langsenlehner, U.
- Thurner, E.M.
- Stojakovic, T.
- Pichler, Martin
- Gerger, A.
- Kapp, K.S.
- Langsenlehner, T.
- Universität Augsburg
- Elsevier BV
Time of origin
- 2015
Other Objects (12)
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
The role of microRNAs in breast cancer stem cells
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Best of ASCO 2022: bladder cancer
C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
The role of microRNAs in breast cancer stem cells
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Best of ASCO 2022: bladder cancer
C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
The role of microRNAs in breast cancer stem cells
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Best of ASCO 2022: bladder cancer
C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1